Showing results (331-340 of 1,761) with videos related to

Sort By:
Pageof 177
Cellular & Molecular Immunology|February 17, 2015
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5AChen Yang, Xinhao Zhao, Dakang Sun, et al.
Cellular & Molecular Immunology|February 10, 2015
Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltrationStephanie Mathews, Dechun Feng, Igor Maricic, et al.
Cellular & Molecular Immunology|February 3, 2015
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirusNaru Zhang, Rudragouda Channappanavar, Cuiqing Ma, et al.
Cellular & Molecular Immunology|February 3, 2015
IRG1 induced by heme oxygenase-1/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine productionMd Jamal Uddin, Yeonsoo Joe, Seul-Ki Kim, et al.
Cellular & Molecular Immunology|February 3, 2015
Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infectionSekar Tamil Selvi Chitradevi, Gurpreet Kaur, Sivaramakrishna Uppalapati, et al.
Cellular & Molecular Immunology|July 2, 2020
PD-L1+ exosomes from bone marrow-derived cells of tumor-bearing mice inhibit antitumor immunityYan Sun, Jufeng Guo, Lei Yu, et al.
Cellular & Molecular Immunology|July 3, 2020
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implicationsYuanyuan Zhang, Zemin Zhang
Cellular & Molecular Immunology|October 16, 2012
Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunityYi Zhang, Ruihua Zhang, Huafeng Zhang, et al.
Cellular & Molecular Immunology|August 20, 2025
SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic targetWen Si, Sijin Cheng, Haiyin He, et al.
Cellular & Molecular Immunology|March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.
Pageof 177